Details for Patent: 8,807,861
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,807,861 protect, and when does it expire?
Patent 8,807,861 protects AXIRON and is included in one NDA.
This patent has seventeen patent family members in fourteen countries.
Summary for Patent: 8,807,861
| Title: | Spreading implement |
| Abstract: | An implement 1 for applying a volume of liquid to a treatment surface can include a support 3 onto which is mounted a receptacle 2, the receptacle defining a reservoir space 4 which receives the liquid. The receptacle includes a wall 6 having a working surface that is used to spread the liquid over the treatment surface. The wall 6 is resiliently deformable so in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement has a specific application in applying a transdermal lotion to the axilla area of the user. A system for transdermal administration of a physiological active agent from a liquid composition and a method of using this system are described. |
| Inventor(s): | Bayly; Peter (Doreen, AU), Bayly; Mark Simon (Eltham North, AU), Ahlstrom; Magnus (Nunawading, AU), Watkinson; Adam Charles (Somerset, AU) |
| Assignee: | Acrux DDS Pty Ltd. (West Melbourne, Victoria, AU) |
| Application Number: | 13/836,056 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,807,861 |
|
Patent Claim Types: see list of patent claims | Composition; Delivery; Device; Use; |
Drugs Protected by US Patent 8,807,861
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly And Co | AXIRON | testosterone | SOLUTION, METERED;TRANSDERMAL | 022504-001 | Nov 23, 2010 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | A METHOD OF TRANSDERMAL ADMINISTRATION OF A PHYSIOLOGICALLY ACTIVE AGENT TO A SUBJECT. | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,807,861
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2007343579 | See Plans and Pricing | |||
| Brazil | PI0720945 | See Plans and Pricing | |||
| Canada | 2674661 | See Plans and Pricing | |||
| China | 101636194 | See Plans and Pricing | |||
| Eurasian Patent Organization | 015473 | See Plans and Pricing | |||
| Eurasian Patent Organization | 200900987 | See Plans and Pricing | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
